Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex

Neuroscience Letters

Volumn 336, Issue 3, 2003, Pages 171-174

  Maeda, Jun ^a,b,c   Suhara, Tetsuya ^a,b   Okauchi, Takashi ^a,b,c   Semba, Jun'ichi ^b,d  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c 141 0032   (Japan)

^d OPEN UNIVERSITY OF JAPAN   (Japan)

Author keywords

Dopamine; Metabotropic glutamate receptor; Microdialysis; Phencyclidine; Prefrontal cortex

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; GLYCINE DERIVATIVE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; PHENCYCLIDINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

EID: 0037461581     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01261-2     Document Type: Article

References (24)

1. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:1998;5545-5554.
2. Bruton R.K., Ge J., Barnes N.M. Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo. Eur. J. Pharmacol. 369:1999;175-181.
3. Cartmell J., Perry K.W., Salhoff C.R., Monn J.A., Schoepp D.D. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat. J. Neurochem. 75:2000;1147-1154.
4. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem. 75:2000;889-907.
5. Feenstra M.G., Botterblom M.H., van Uum J.F. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J. Neurochem. 70:1998;1104-1113.
6. Hondo H., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. The effect of phencyclidine on the basal and high potassium evoked extracellular GABA levels in the striatum of freely-moving rats: an in vivo microdialysis study. Brain Res. 671:1995;54-62.
7. Hu G., Duffy P., Swanson C., Ghasemzadeh M.B., Kalivas P.W. The regulation of dopamine transmission by metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 289:1999;412-416.
8. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
9. Jentsch J.D., Redmond D.E. Jr, Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 277:1997;953-955.
10. 11C]WAY-100635: effect of endogenous serotonin. Synapse. 40:2001;122-129.
11. McCullough L.D., Salamone J.D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577:1992;1-9.
12. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
13. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th Edition:1998;Academic Press, San Diego, CA.
14. Petralia R.S., Wang Y.X., Niedzielski A.S., Wenthold R.J. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience. 71:1996;949-976.
15. 2A receptors. NeuroReport. 11:2000;3611-3614.
16. Pintor A., Potenza R.L., Domenici M.R., Tiburzi F., Reggio R., Pezzola A., Popoli P. Age-related decline in the functional response of striatal group I mGlu receptors. NeuroReport. 11:2000;3033-3038.
17. Romano C., Sesma M.A., McDonald C.T., O'Malley K., van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355:1995;455-469.
18. B receptor agonists and antagonists. Brain Res. 630:1993;28-31.
19. Schoepp D.D., Jane D.E., Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38:1999;1431-1476.
20. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904.
21. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14:1994;3005-3018.
22. Testa C.M., Friberg I.K., Weiss S.W., Standaert D.G. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J. Comp. Neurol. 390:1998;5-19.
23. Verma A., Moghaddam B. Regulation of striatal dopamine release by metabotropic glutamate receptors. Synapse. 28:1998;220-226.
24. Yonezawa Y., Kuroki T., Kawahara T., Tashiro N., Uchimura H. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur. J. Pharmacol. 341:1998;45-56.